Surgery to implant a total hip replacement (THR) is very successful in reducing pain and restoring function. This procedure has become more prevalent, and projections estimate further increases in demand. However, complications can arise, and current diagnostic techniques often fail to expose underlying issues before they result in a catastrophic failure that requires revision surgery. An instrumented implant, with embedded sensors capable of real time condition monitoring, would be an attractive proposition to incorporate within a THR. Continued advances in the performance and miniaturisation of electronic components, embedded systems, sensing and wireless communications have given the tools and resources medical device manufacturers need to innovate in the field of implantable medical devices. Smart implants are already being widely used in healthcare including pacemakers, cochlear implants, glucose monitors and insulin pumps however, a widely used smart THR has not yet been realised. Since the implantation of the first instrumented hip implant in the 1960s there have been several in vitro studies monitoring levels of implant loosening. Additionally, significant research has been conducted using instrumented THRs to perform in vivo measurement of biomechanical metrics, including force and moments. To date less than 100 patients have successfully received an instrumented implant. The results of these studies have aided researchers, designers and surgeons in wider research projects, however, the motivation behind the work was to provide discrete biomechanical data sets and not provide real-time condition monitoring of an implants performance or highlight early indications for revision surgery. If in vivo sensing within a THR is to be achieved and adopted in regular clinical practice then the following challenges need to be addressed: choice of the sensing method, biocompatibility and integration within the implant, power supply, communication, and regulatory considerations.
Dual mobility (DM) implants are being increasingly used for total hip arthroplasties due to the additional range of motion and joint stability they afford over more traditional implant types. Currently, there are no reported methods for monitoring their motions under realistic operating conditions while in vitro and, therefore, it is challenging to predict how they will function under clinically relevant conditions and what failure modes may exist. This study reports the development, calibration, and validation of a novel inertial tracking system that directly mounts to the mobile liner of DM implants. The tracker was custom built and based on a miniaturized, off-the-shelf inertial measurement unit (IMU) and employed a gradient-decent sensor fusion algorithm for amalgamating nine degree-of-freedom IMU readings into three-axis orientation estimates. Additionally, a novel approach to magnetic interference mitigation using a fixed solenoid and magnetic field simulation was evaluated. The system produced orientation measurements to within 1.0° of the true value under ideal conditions and 3.9° with a negligible drift while in vitro, submerged in lubricant, and without a line of sight.
An instrumented total hip replacement (THR) implant capable of remote and continuous monitoring would be an attractive prospect for a surgeon to conveniently track the recovery of their patients. Measuring the relative motion of the prosthesis components would provide insight into joint kinematics and contribute to the detection of adverse events including impingement and subluxation. The aim of this study was to develop a sensing system to measure the relative orientation and translation of the prosthesis components. A tri-axis magnetometer and a permanent magnet were integrated into clinically available THR components, forming a magnetic position and orientation sensing system. A robotic arm was used to articulate the components through controlled motion routines and record the orientation of the components. The output of the robot arm and a camera tracking system were used to validate the performance of the sensing system. The sensing system measured the relative orientation of the components to two degrees of freedom with an RMSE of <4.0° and measured the displacement of the femoral head during an impingement-driven subluxation motion with an RMSE of 0.2 mm. This proof-of-concept work has shown that magnetic sensing technology can track the position and orientation of THR components. With further development, this sensing method could feature within an instrumented THR implant.